Exclusive radiotherapy for primary squamous cell carcinoma of the vagina

Radiotherapy and Oncology

Volumn 85, Issue 3, 2007, Pages 362-370

  de Crevoisier, Renaud ^a   Sanfilippo, Nicholas ^a   Gerbaulet, Alain ^a   Morice, Philippe ^a   Pomel, Christophe ^a   Castaigne, Damiene ^a   Pautier, Patricia ^a   Lhomme, Catherine ^a   Duvillard, Pierre ^a   Haie meder, Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Brachytherapy; Radiation therapy; Vagina

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COLON OBSTRUCTION; CONSTIPATION; DIARRHEA; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FISTULA; HUMAN; HYDRONEPHROSIS; INTESTINE NECROSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECTOVAGINAL FISTULA; RECTUM STENOSIS; SQUAMOUS CELL CARCINOMA; STENOSIS; SURVIVAL RATE; TREATMENT RESPONSE; URETER OBSTRUCTION; URETEROVAGINA FISTULA; VAGINA CARCINOMA; VAGINA STENOSIS;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; VAGINAL NEOPLASMS;

EID: 36749059450     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.09.015     Document Type: Article

References (65)

1. Parker S.L., Tong T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J Clin 47 (1997) 5-27
2. Johnston Jr. G.A., Klotz J., and Boutselis J.G. Primary invasive carcinoma of the vagina. Surg Gynecol Obstet 156 (1983) 34-40
3. Ali M.M., Huang D.T., Goplerud D.R., Howells R., and Lu J.D. Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor. Cancer 77 (1996) 1934-1939
4. Eddy G.L., Marks Jr. R.D., Miller III M.C., and Underwood Jr. P.B. Primary invasive vaginal carcinoma. Am J Obstet Gynecol 165 (1991) 292-296 discussion 6-8.
5. Peters III W.A., Kumar N.B., and Morley G.W. Carcinoma of the vagina. Factors influencing treatment outcome. Cancer 55 (1985) 892-897
6. Dixit S., Singhal S., and Baboo H.A. Squamous cell carcinoma of the vagina: a review of 70 cases. Gynecol Oncol 48 (1993) 80-87
7. Perez C.A., Camel H.M., Galakatos A.E., et al. Definitive irradiation in carcinoma of the vagina: long-term evaluation of results. Int J Radiat Oncol Biol Phys 15 (1988) 1283-1290
8. Leung S., and Sexton M. Radical radiation therapy for carcinoma of the vagina-impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970-1990. Int J Radiat Oncol Biol Phys 25 (1993) 413-418
9. Gerbaulet A., Michel G., Haie-Meder C., et al. The role of low dose rate brachytherapy in the treatment of cervix carcinoma. Experience of the Gustave-Roussy Institute on 1245 patients. Eur J Gynaecol Oncol 16 (1995) 461-475
10. ICRU. International Commission of Radiation Units and Measurements (ICRU). Dose and volume specification for reporting intracavitary therapy in gynecology, ICRU Report, 38. Bethesda, MD: ICRU, 1985.
11. Chassagne D., Sismondi P., Horiot J.C., et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26 (1993) 195-202
12. Chu A.M., and Beechinor R. Survival and recurrence patterns in the radiation treatment of carcinoma of the vagina. Gynecol Oncol 19 (1984) 298-307
13. Otton G.R., Nicklin J.L., Dickie G.J., et al. Early-stage vaginal carcinoma - an analysis of 70 patients. Int J Gynecol Cancer 14 (2004) 304-310
14. Pingley S., Shrivastava S.K., Sarin R., et al. Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys 46 (2000) 101-108
15. Benedet J.L., Murphy K.J., Fairey R.N., and Boyes D.A. Primary invasive carcinoma of the vagina. Obstet Gynecol 62 (1983) 715-719
16. Reddy S., Saxena V.S., Lee M.S., et al. Results of radiotherapeutic management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 21 (1991) 1041-1044
17. Chyle V., Zagars G.K., Wheeler J.A., Wharton J.T., and Delclos L. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35 (1996) 891-905
18. Nori D., Hilaris B.S., Stanimir G., and Lewis Jr. J.L. Radiation therapy of primary vaginal carcinoma. Int J Radiat Oncol Biol Phys 9 (1983) 1471-1475
19. Stryker J.A. Radiotherapy for vaginal carcinoma: a 23-year review. Br J Radiol 73 (2000) 1200-1205
20. Prempree T. Role of radiation therapy in the management of primary carcinoma of the vagina. Acta Radiol Oncol 21 (1982) 195-201
21. Kirkbride P, Fyles A, Rawlings GA, et al. Carcinoma of the vagina - experience at the Princess Margaret Hospital (1974-1989). Gynecol Oncol 1995;56:435-43.
22. Urbanski K., Kojs Z., Reinfuss M., and Fabisiak W. Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60 (1996) 16-21
23. Stock R.G., Mychalczak B., Armstrong J.G., Curtin J.P., and Harrison L.B. The importance of brachytherapy technique in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 24 (1992) 747-753
24. Prempree T., Viravathana T., Slawson R.G., Wizenberg M.J., and Cuccia C.A. Radiation management of primary carcinoma of the vagina. Cancer 40 (1977) 109-118
25. Davis K.P., Stanhope C.R., Garton G.R., Atkinson E.J., and O'Brien P.C. Invasive vaginal carcinoma: analysis of early-stage disease. Gynecol Oncol 42 (1991) 131-136
26. Lamoreaux W.T., Grigsby P.W., Dehdashti F., et al. FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 62 (2005) 733-737
27. Frank S.J., Jhingran A., Levenback C., and Eifel P.J. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62 (2005) 138-147
28. Perez C.A., Grigsby P.W., Garipagaoglu M., Mutch D.G., and Lockett M.A. Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44 (1999) 37-45
29. Vavra N., Seifert M., Kucera H., and Weghaupt K. Radiotherapy of primary vaginal carcinoma and effects of histological and clinical factors on the prognosis. Strahlenther Onkol 167 (1991) 1-6
30. Gesta P., Fenton J., Mathieu G., et al. Vaginal cancer: primary invasive squamous cell carcinoma in adults. Bull Cancer 76 (1989) 591-604
31. Niehoff P., Dietrich J., Ostertag H., et al. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Strahlenther Onkol 182 (2006) 102-107
32. Peters III W.A., Kumar N.B., Andersen W.A., and Morley G.W. Primary sarcoma of the adult vagina: a clinicopathologic study. Obstet Gynecol 65 (1985) 699-704
33. Senekjian E.K., Frey K.W., Anderson D., and Herbst A.L. Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer 60 (1987) 1319-1324
34. Kucera H., and Vavra N. Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40 (1991) 12-16
35. Rubin S.C., Young J., and Mikuta J.J. Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up. Gynecol Oncol 20 (1985) 346-353
36. MacNaught R., Symonds R.P., Hole D., and Watson E.R. Improved control of primary vaginal tumours by combined external-beam and interstitial radiotherapy. Clin Radiol 37 (1986) 29-32
37. Samant R., Tam T., and Dahrouge S.C.E. Radiotherapy for the treatment of primary vaginal cancer. Radiother Oncol 77 (2005) 133-136
38. Tewari K.S., Cappuccini F., Puthawala A.A., et al. Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy. Cancer 91 (2001) 758-770
39. Girinsky T., Rey A., Roche B., et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 27 (1993) 1051-1056
40. Lee W.R., Marcus Jr. R.B., Sombeck M.D., et al. Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time. Int J Radiat Oncol Biol Phys 29 (1994) 983-988
41. Steed H.L., Pearcey R.G., Capstick V., and Honore L.H. Invasive squamous cell carcinoma of the vagina during pregnancy. Obstet Gynecol 100 (2002) 1105-1108
42. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
43. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
44. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
45. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
46. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
47. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
48. Slayton R.E., Blessing J.A., Beecham J., and DiSaia P.J. Phase II trial of etoposide in the management of advanced or recurrent squamous cell carcinoma of the vulva and carcinoma of the vagina: a Gynecologic Oncology Group Study. Cancer Treat Rep 71 (1987) 869-870
49. Muss H.B., Bundy B.N., and Christopherson W.A. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study. Am J Clin Oncol 12 (1989) 142-144
50. Thigpen J.T., Blessing J.A., Homesley H.D., Berek J.S., and Creasman W.T. Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study. Gynecol Oncol 23 (1986) 101-104
51. Roberts W.S., Hoffman M.S., Kavanagh J.J., et al. Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecol Oncol 43 (1991) 233-236
52. Evans L.S., Kersh C.R., Constable W.C., and Taylor P.T. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies. Int J Radiat Oncol Biol Phys 15 (1988) 901-906
53. Dalrymple J.L., Russell A.H., Lee S.W., et al. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 14 (2004) 110-117
54. Samant R., Lau B., Choan E., Le T., and Tam T. Primary vaginal cancer treated with concurrent chemoradiation using cis-platinum. Int J Radiat Oncol Biol Phys (2007)
55. Potter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83 (2007) 148-155
56. Briot E, DeCrevoisier R, Petrow P, et al. Dose-volume histogram analysis for tumor and organs at risk in intracavitary brachytherapy of cervical cancer with the use of MRI. Radiother Oncol 2002; Annual ESTRO Meeting 2002, S163:Abstr.514.
57. Siebert F.A., Born T., Haring S., Seefeld F., and Kovacs G. A dosimetric analysis of interstitial intensity modulated implants for pelvic recurrences, base of tongue and orbita tumors with specific references to the ICRU-58. Radiother Oncol 79 (2006) 298-303
58. Hintz B.L., Kagan A.R., Chan P., et al. Radiation tolerance of the vaginal mucosa. Int J Radiat Oncol Biol Phys 6 (1980) 711-716
59. Dancuart F., Delclos L., Wharton J.T., and Silva E.G. Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failures analysis - the M.D. Anderson Hospital experience 1955-1982. Int J Radiat Oncol Biol Phys 14 (1988) 745-749
60. Pride G.L., and Buchler D.A. Carcinoma of vagina 10 or more years following pelvic irradiation therapy. Am J Obstet Gynecol 127 (1977) 513-517
61. Puthawala A., Syed A.M., Nalick R., McNamara C., and DiSaia P.J. Integrated external and interstitial radiation therapy for primary carcinoma of the vagina. Obstet Gynecol 62 (1983) 367-372
62. Mock U., Kucera H., Fellner C., Knocke T.H., and Potter R. High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. Int J Radiat Oncol Biol Phys 56 (2003) 950-957
63. Kushner D.M., Fleming P.A., Kennedy A.W., Wilkinson D.A., Lee E., and Saffle P.A. High dose rate (192)Ir afterloading brachytherapy for cancer of the vagina. Br J Radiol 76 (2003) 719-725
64. Roeske J.C., Lujan A., Rotmensch J., Waggoner S.E., Yamada D., and Mundt A.J. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48 (2000) 1613-1621
65. Mundt A.J., Lujan A.E., Rotmensch J., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52 (2002) 1330-1337